Oppenheimer analyst Michael Wiederhorn is updating its Amedisys (AMED) model following the Q4 earnings release. Amedisys is currently in the ...

Truist Financial analyst David S Macdonald maintained a Hold rating on Amedisys (AMED – Research Report) today and set a price target of ...

If you’re on the fence about investing in Amedisys, Inc., LifeStance Health Group or Inc. because you’re not sure how they measure up, it’s important to compare them on a few factors before making ...

Unite.AI is committed to rigorous editorial standards. We may receive compensation when you click on links to products we review. Please view our affiliate disclosure. Creating a strong brand identity ...

The chart above depicts the trend in analyst earnings per share (EPS) forecasts for Amedisys Inc for the upcoming quarter. Analysts have reduced this quarter's expectations by -12.1% for EPS from 1.21 ...

For the quarter ended December 2024, Amedisys (AMED) reported revenue of $598.05 million, up 4.8% over the same period last year. EPS came in at $0.96, compared to $0.94 in the year-ago quarter.

BATON ROUGE, La., Feb. 26, 2025 (GLOBE NEWSWIRE) -- Amedisys, Inc. (NASDAQ: AMED) today reported its financial results for the three-month period and year ended December 31, 2024. Three-Month Periods ...

Amedisys Inc. (Nasdaq: AMED) experienced growth in home health during the fourth quarter of 2024, despite incurring merger-related costs from its pending acquisition by UnitedHealth Group (NYSE: UNH).

BATON ROUGE, La. (AP) — BATON ROUGE, La. (AP) — Amedisys Inc. (AMED) on Wednesday reported a fourth-quarter loss of $20.4 million, after reporting a profit in the same period a year earlier.

Amedisys (AMED) came out with quarterly earnings of $0.96 per share, missing the Zacks Consensus Estimate of $1.05 per share. This compares to earnings of $0.94 per share a year ago. These figures ...

In light of the pending merger of the Company with UnitedHealth Group Incorporated, Amedisys will not conduct a quarterly earnings call to discuss the fourth quarter and year end results.